Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Laurus Labs has announced that its board has approved the acquisition of up to 26% of the share capital in Kurnool Renewables, a special purpose vehicle (SPV) and subsidiary of Ecoren Energy India ...

“We are excited to collaborate with Scienture to enhance its commercial effectiveness,” said Paul Mignon, President, Deployment Solutions, Syneos Health. “Our team is committed to delivering tailored ...

KAM literacy differs dramatically by executive ... technology and the current systems that most pharmaceutical companies deploy. Traditional sales software has been essentially a call reporting ...

Orion Corporation, the globally operating Finnish pharmaceutical company, has opened its Biologics R&D Centre at Babraham ...

We are delighted to welcome Stephen to TScan at this stage of growth for the Company,” said Gavin MacBeath, Ph.D., Chief Executive Officer. “His robust commercial leadership experience includes over ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

FDA Approval of Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended De ...

Alvotech will conduct a business update conference call and live webcast on Thursday March 27, 2025, at 8:00 am ET (12:00pm ...

The passage of comprehensive healthcare reform will have a dramatic impact on pharmaceutical sales in the United States. The tightening of regulations and product formularies will result in less ...

Harmony Biosciences has named Adam Zaeske its next chief commercial officer, luring the Takeda veteran back from Europe to ...

Announced in December 2024, David Enloe joins as the division’s CEO. He has experience leading life science CDMOs such as ...